Year |
Title |
Altmetric |
2021
|
White matter integrity after cannabidiol administration for treatment resistant epilepsy
2021
|
|
2020
|
Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy.
Epilepsy and Behavior.
2020
|
|
2019
|
Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program.
Epilepsy and Behavior.
201-206.
2019
|
|
2019
|
fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
Epilepsy and Behavior.
96:114-121.
2019
|
|
2019
|
Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol.
Epilepsy and Behavior.
95:131-136.
2019
|
|
2019
|
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
Epilepsy and Behavior.
95:10-17.
2019
|
|
2018
|
Cannabis for the Treatment of Epilepsy: an Update.
Current Neurology and Neuroscience Reports.
18.
2018
|
|
2018
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.
Epilepsy and Behavior.
87:131-136.
2018
|
|
2016
|
White matter abnormalities in patients with treatment-resistant genetic generalized epilepsies
2016
|
|
2015
|
White matter diffusion abnormalities in patients with psychogenic non-epileptic seizures.
Brain Research.
1620:169.
2015
|
|
|
Cannabidiol (CBD) and cognition in epilepsy.
Epilepsy and Behavior.
124.
|
|
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver Hoef.
Epilepsy and Behavior.
(in press).
|
|
|
Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy.
Clinical Pharmacology and Therapeutics.
110.
|
|